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Antioxidant activity in vitro 
FOX reagent preparation [1] 
Working FOX reagent was prepared by adding 10 ml of Reagent 1 (98 mg of (NH4)2Fe(SO4)2x6H2O in 100 
ml of 250 mM H2SO4) to 900 ml of Reagent 2 (95 mg of Xylenol Orange (XO) Na salt and 880 mg of 2,6-di-
t-butyl-4-methylphenol (BHT) in 900 ml of MeOH) giving the final concentrations of 250 μM 
(NH4)2Fe(SO4)2, 125 μM XO, 25 mM H2SO4, and 4 mM BHT. The complete reagent was used within 24 h or 
a new batch was made. The absorbance of the Fe
3+
-XO complex was measured at 560 nm by UV-vis 
spectroscopy (GBC-Cintra 40) with 90% MeOH as a zero probe. 
The procedure includes preparing a standard calibration curve using increasing concentrations (0-200 μM) of 
TBHP incubated with a FOX reagent at room temperature for 30 min until color formation is complete. 2mM 
Standard solution of TBHP was prepared by dilution with MeOH.  
Standard probe preparation 
The standard solution of TBHP was prepared in the same manner without the sample aliquot, which was 
substituted with H2O. After incubation the absorbance was determined at 560 nm (AS). 
Blank probe preparation  
In all experiments a blank was carried out for determination of the possible activity in the absence of 
substrate during the incubation period. The blank contained 0.950 ml of FOX reagent and 0.050 ml of H2O 
instead of the sample. After incubation the absorbance was determined at 560 nm (A0). 
 
                                                          
[1] Gao S, Miller M, Han XQ (2005) Peptide antioxidants from soy protein, EP 1 593 685 A1 
 S2 
Vitamin C, well-known antioxidant, was used as a positive control. The absorbance read at the 
spectrophotometer for each sample varies in relation to the concentration of TBHP contained in the sample 
being tested. All analyses were performed in triplicate and average values were taken. The direct antioxidant 
activity (the percentage of consumed TBHP, Δ) was calculated from the equation 
Δ = 100 x (A-As)/(As-A0)  
where A, As, and A0 represent absorbances of the tested compound, starting (TBHP+FOX), and blank (FOX) 
probes, respectively. Obtained values are recalculated to the activities relative to the equimolar concentration 
of vitamin C according to the formula: 
Aox vs vit C = (Δ/Δvit C)/(M/Mvit C) 
where Δ and Δvit C represent the direct antioxidant capacity of the tested compound and vitamin C, 




Aliquots of 0.050 mL of prepared solutions of fullerosomes (0.02 mg/mL concentrated), were mixed with the 
0.050 mL of the 2mM solution of peroxide and diluted with 0.900 mL of water (corresponds to mixed 
0.002mg/mL of sample solution and 200μM standard peroxide solution in 1:1 (V/V) ratio). Mixture was than 
vortexed for 1 min and incubated in stoppered vial at room temperature, for 10 min. From each incubated 
mixture three aliquots of 0.050 mL were taken and mixed with 0.950 mL of FOX reagent. Absorbance (A) at 
560 nm was measured after 80 min of incubation at room temperature, in aim to determine the percentage of 
consumed peroxide (direct antioxidant activity). 
Spectral data of compounds 1-12 
Fullerene carbons are labelled as Cf, and pyrrolidinic nuclei as C/H
pyrr
. The glycine moieties incorporated 






 starting from the C terminus. Corresponding 
GABA-fragments are labelled in the same manner as G, G' and G'' and their atoms are numbered in the order 
of priority. For the clarity purpose, the example of the hexapeptide 12 with schematic representation of the 
numbering is given below Table S1 (page S6). 
Fp-GABA-OH (Fp-G-OH) 1 (IR, UV and mass spectra were in accordance with the published data [2]. 
Starting from tert-butyl ester (1.19 g, 1.31 mmol) in TFA/DCM (1:1, 40 mL) the acid 1 (1.10 g, 99%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ= 4.4 (CH2
pyrr.
,overlapped with CD3OH signal), 3.26 (t, 
J=7.0 Hz, 2H, CH2
4
), 2.73 (t, J=7.0 Hz, 2H, CH2
2




H NMR (500 MHz, 
CDCl3/CF3COOD): δ= 5.84 (d, J=12.0 Hz, 2H, CH2
pyrr.
), 5.07 (d, J=12.0 Hz, 2H, CH2
pyrr.
), 4.23 (t, J=8.0 Hz, 
2H, CH2
4
), 2.94 (t, J=6.5 Hz, 2H, CH2
2




C NMR (125 MHz, 
CDCl3/CS2/CF3COOD): δ=179.81 (COOH), 150.07, 149.75, 148.00, 147.01, 146.91, 146.80, 146.69, 146.43, 
146.27, 145.95, 145.91, 145.50, 144.98, 144.87, 144.68, 144.20, 143.33, 143.29, 142.69, 142.55, 142.54, 










Fp-GABA2-OH (Fp-G'-G-OH) 2 
Starting from tert-butyl ester (130 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 2 (120 mg, 99%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=7.58 (br.t, J=5.0 Hz, 1H, NH
GABA
), 4.66 (s, 4H, 
CH2
pyrr.
), 3.33 (t, J=6.5 Hz, 2H, CH2
4'
), 3.32 (q, J=7.0 Hz, 2H, CH2
4
), 2.58 (t, J=7.0 Hz, 2H, CH2
2'
), 2.37 (t, 
J=7.0 Hz, 2H, CH2
2
), 2.30 (quintet, J=7.0 Hz, 2H, CH2
3'




C NMR (125 
                                                          
[2] Bjelakovic MS, Godjevac DM, Milic DR (2007) Synthesis and antioxidant properties of fullero-steroidal covalent 
conjugates, Carbon 45:2260-2265. 
 S3 
MHz, CDCl3/CS2/CD3OH): δ=175.61 (COOH), 173.62 (CONH), 153.64 (Cf-2, 5, 8, 10), 147.03 (Cf-52, 60), 
145.98 (Cf-32, 39, 41, 48), 145.79 (Cf-3, 4, 25, 26), 145.43 (Cf-51, 53, 56, 59), 145.30 (Cf-21, 30), 145.21 
(Cf-14, 19, 23, 28), 145.00 (Cf-49, 50, 54, 55), 144.21 (Cf-33, 38, 42, 47), 142.80 (Cf-31, 40), 142.36 (Cf-35, 
36, 57, 58), 141.78 (Cf-13, 20, 22, 29), 141.75 (Cf-34, 37, 43, 46), 141.62 (Cf-16, 17, 44, 45), 139.88 (Cf-15, 















); IR: ν=3438, 2928, 1672, 1429, 1186, 1137 cm-1; UV/Vis 






); ESI-TOF-MS: m/z: 
calcd for C70H19N2O3: 935.13902 [M+H]
+`
, found 935.14058. 
Fp-GABA3-OH(Fp-G''-G'-G-OH) 3 
Starting from tert-butyl ester (140 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 3 (131 mg, 99%) was 
obtained. 
1
H NMR(500 MHz, CDCl3/CS2): δ=7.72 (br.t, J=6.0 Hz, 1H, NH
GABA'
), 7.52 (br.t, J=5.5 Hz, 1H, 
NH
GABA
), 4.62 (s, 4H, CH2
pyrr.
), 3.31 (t, J=7.0 Hz, 2H, CH2
4''
), 3.27 (q, J=7.0 Hz, 2H, CH2
4'
), 3.26 (t, J=7.0 
Hz, 2H, CH2
4
), 2.57 (t, J=7.5 Hz, 2H, CH2
2''
), 2.34 (t, J=7.0 Hz, 2H, CH2
2
), 2.30 (quintet, J=7.0 Hz, 2H, 
CH2
3''
), 2.23 (t, J=7.5 Hz, 2H, CH2
2'
), 1.83 (quintet, J=7.0 Hz, 2H, CH2
3'








), 153.85 (Cf-2, 5, 8, 
10), 147.09 (Cf-52, 60), 146.03 (Cf-32, 39, 41, 48), 145.84 (Cf-3, 4, 25, 26), 145.53 (Cf-51, 53, 56, 59), 
145.37 (Cf-21, 30), 145.25 (Cf-14, 19, 23, 28), 145.06 (Cf-49, 50, 54, 55), 144.28 (Cf-33, 38, 42, 47), 142.86 
(Cf-31, 40), 142.41 (Cf-35, 36, 57, 58), 141.83 (Cf-13, 20, 22, 29), 141.83 (Cf-34, 37, 43, 46), 141.68 (Cf-16, 




















); IR: ν=3423, 3306, 3093, 2935, 1648, 1554, 1429, 1186 1137 cm-1; UV/Vis (CHCl3): λmax (ε)=430 






); ESI-TOF-MS: m/z: calcd for 
C74H26N3O4: 1020.19178 [M+H]
+
, found 1020.19315. 
Fp-GABA-Gly-OH(Fp-G-Gly-OH) 4 
Starting from tert-butyl ester (125 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 4 (117 mg, 99%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=7.76 (br.t, J=5.5 Hz, 1H, NH
Gly
), 4.52 (s, 4H, 
CH2
pyrr.
), 3.98 (d, J=5.5 Hz, 2H, CH2
Gly
), 3.23 (t, J=7.0 Hz, 2H, CH2
4
), 2.64 (t, J=7.0 Hz, 2H, CH2
2
), 2.28 




C NMR (125 MHz, CDCl3): δ=173.72 (CONH), 171.31 (COOH), 154.15 
(Cf-2, 5, 8, 10), 146.82 (Cf-52, 60), 145.77 (Cf-32, 39, 41, 48), 145.59 (Cf-3, 4, 25, 26), 145.46 (Cf-51, 53, 56, 
59), 145.17 (Cf-21, 30), 144.98 (Cf-14, 19, 23, 28), 144.81 (Cf-49, 50, 54, 55), 144.06 (Cf-33, 38, 42, 47), 
142.62 (Cf-31, 40), 142.16 (Cf-35, 36, 57, 58), 141.69 (Cf-13, 20, 22, 29), 141.61 (Cf-34, 37, 43, 46), 141.43 











); IR: ν=3428, 2925, 1656, 1638, 1545, 1187, 
1138cm
-1







ESI-TOF-MS: m/z: calcd for C68H15N2O3: 907.10772 [M+H]
+






Starting from tert-butyl ester (133 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 5 (124 mg, 99%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=7.93 (br.t, J=5.0 Hz, 1H, NH
Gly2
), 7.86 (br.t, J=5.0 
Hz, 1H, NH
Gly1
), 4.58 (s, 4H, CH2
pyrr.
), 3.95 (d, J=5.5 Hz, 2H, CH2
Gly2
), 3.94 (d, J=6.0 Hz, 2H, CH2
Gly1
), 3.28 
(t, J=7.0 Hz, 2H, CH2
4
), 2.65 (t, J=7.0 Hz, 2H, CH2
2




C NMR (125 
MHz, CDCl3/CS2/CD3OH): δ=173.92 (CO
GABA
), 171.19 (COOH), 169.71 (CO
Gly2
), 153.96 (Cf-2, 5, 8, 10), 
146.87 (Cf-52, 60), 145.83 (Cf-32, 39, 41, 48), 145.64 (Cf-3, 4, 25, 26), 145.44 (Cf-51, 53, 56, 59), 145.20 
(Cf-21, 30), 145.04 (Cf-14, 19, 23, 28), 144.86 (Cf-49, 50, 54, 55), 144.10 (Cf-33, 38, 42, 47), 142.66 (Cf-31, 
40), 142.22 (Cf-35, 36, 57, 58), 141.69 (Cf-13, 20, 22, 29), 141.65 (Cf-34, 37, 43, 46), 141.48 (Cf-16, 17, 44, 













); IR: ν=3432, 2926, 1669, 1540, 1423, 1188, 1136, 
1032 cm
-1







); ESI-TOF-MS: m/z: calcd for C70H18N3O4: 964.12918 [M+H]
+









Starting from tert-butyl ester (140 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 6 (135 mg, 98%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=8.09 (br.t, J=5.5 Hz, 1H, NH
Gly3
), 8.06 (br.t, J=5.0 
Hz, 1H, NH
Gly2
), 7.91 (br.t, J=6.0 Hz, 1H, NH
Gly1
), 4.60 (s, 4H, CH2
pyrr.
), 3.942 (d, J=5.5 Hz, 2H, CH2
Gly1
), 
3.934 (d, J=5.5 Hz, 2H, CH2
Gly3
), 3.931 (d, J=6.0 Hz, 2H, CH2
Gly2
), 3.30 (t, J=7.0 Hz, 2H, CH2
4
), 2.66 (t, 
J=7.0 Hz, 2H, CH2
2




C NMR (125 MHz, CDCl3/CS2/CD3OH): 
δ=174.38 (COGABA), 171.39 (COOH), 170.10 (COGly3), 169.82 (COGly2), 153.91 (Cf-2, 5, 8, 10), 146.91 (Cf-
52, 60), 145.87 (Cf-32, 39, 41, 48), 145.68 (Cf-3, 4, 25, 26), 145.44 (Cf-51, 53, 56, 59), 145.22 (Cf-21, 30), 
145.08 (Cf-14, 19, 23, 28), 144.90 (Cf-49, 50, 54, 55), 144.13 (Cf-33, 38, 42, 47), 142.70 (Cf-31, 40), 142.25 
(Cf-35, 36, 57, 58), 141.71 (Cf-13, 20, 22, 29), 141.68 (Cf-34, 37, 43, 46), 141.52 (Cf-16, 17, 44, 45), 139.78 















); IR: ν=3407, 2928, 1662, 1543, 1424, 1190, 
1136, 1078, 1030 cm
-1







); ESI-TOF-MS: m/z: calcd for C72H21N4O5: 1021.15065 [M+H]
+
, found 1021.15062. 
Fp-GABA2-Gly-OH (Fp-G'-G-Gly-OH) 7 
Starting from tert-butyl ester (136 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 7 (126 mg, 98%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=7.76 (br.t, J=5.5 Hz, 1H, NH
Gly
), 7.74 (br.t, J=5.5 Hz, 
1H, NH
GABA
), 4.70 (s, 4H, CH2
pyrr.
), 3.94 (d, J=5.5 Hz, 2H, CH2
Gly
), 3.36 (t, J=7.5 Hz, 2H, CH2
4'
), 3.31 (q, 
J=6.5 Hz, 2H, CH2
4
), 2.56 (t, J=7.0 Hz, 2H, CH2
2'
), 2.31 (t, J=7.0 Hz, 2H, CH2
2
), 2.30 (quintet, J=7.0 Hz, 
2H, CH2
3'









), 171.69 (COOH), 153.50 (Cf-2, 5, 8, 10), 147.04 (Cf-52, 60), 146.00 (Cf-32, 39, 
41, 48), 145.80 (Cf-3, 4, 25, 26), 145.39 (Cf-51, 53, 56, 59), 145.31 (Cf-21, 30), 145.23 (Cf-14, 19, 23, 28), 
145.02 (Cf-49, 50, 54, 55), 144.22 (Cf-33, 38, 42, 47), 142.81 (Cf-31, 40), 142.37 (Cf-35, 36, 57, 58), 141.79 
(Cf-13, 20, 22, 29), 141.73 (Cf-34, 37, 43, 46), 141.64 (Cf-16, 17, 44, 45), 139.89 (Cf-15, 18, 24, 27), 135.93 

















); IR: ν=3431, 2924, 2854, 1638, 1544, 1430, 1185, 1134, 1077 cm-
1







TOF-MS: m/z: calcd for C72H22N3O4: 992.16048 [M+H]
+






Starting from tert-butyl ester (144 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 8 (133 mg, 98%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=7.92 (br.t, J=6.0 Hz, 1H, NH
Gly2
), 7.85 (br.t, J=5.5 
Hz, 1H, NH
Gly1
), 7.68 (br.t, J=5.0 Hz, 1H, NH
GABA
), 4.50 (s, 4H, CH2
pyrr.
), 3.95 (d, J=5.5 Hz, 2H, CH2
Gly1
), 
3.91 (d, J=5.5 Hz, 2H, CH2
Gly2
), 3.29 (q, J=6.5 Hz, 2H, CH2
4
), 3.18 (t, J=7.0 Hz, 2H, CH2
4'
), 2.55 (t, J=7.0 
Hz, 2H, CH2
2'
), 2.32 (t, J=7.0 Hz, 2H, CH2
2
), 2.26 (quintet, J=7.0 Hz, 2H, CH2
3'














), 154.32 (Cf-2, 5, 8, 10), 146.95 (Cf-52, 60), 145.90 (Cf-32, 39, 41, 48), 145.72 (Cf-
3, 4, 25, 26), 145.60 (Cf-51, 53, 56, 59), 145.29 (Cf-21, 30), 145.10 (Cf-14, 19, 23, 28), 144.94 (Cf-49, 50, 54, 
55), 144.19 (Cf-33, 38, 42, 47), 142.75 (Cf-31, 40), 142.29 (Cf-35, 36, 57, 58), 141.80 (Cf-13, 20, 22, 29), 
141.72 (Cf-34, 37, 43, 46), 141.55 (Cf-16, 17, 44, 45), 139.83 (Cf-15, 18, 24, 27), 135.83 (Cf-6, 7, 11, 12), 



















); IR: ν=3423, 2924, 1671, 1543, 1428, 1202, 1136 cm-1; UV/Vis 






); ESI-TOF-MS: m/z: 
calcd for C74H25N4O5: 1049.18195 [M+H]
+








Starting from tert-butyl ester (151 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 9 (142 mg, 99%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=8.16 (br.t, J=6.0 Hz, 1H, NH
Gly2
), 8.13 (br.t, J=6.0 
Hz, 1H, NH
Gly3
), 7.91 (br.t, J=5.5 Hz, 1H, NH
Gly1
), 7.78 (br.t, J=6.0 Hz, 1H, NH
GABA
), 4.53 (s, 4H, CH2
pyrr.
), 
3.92 (d, J=5.5 Hz, 2H, CH2
Gly1
), 3.91 (d, J=5.5 Hz, 2H, CH2
Gly2
), 3.85 (d, J=6.0 Hz, 2H, CH2
Gly3
), 3.26 (q, 
J=6.5 Hz, 2H, CH2
4
), 3.20 (t, J=7.0 Hz, 2H, CH2
4'
), 2.54 (t, J=7.5 Hz, 2H, CH2
2'
), 2.31 (t, J=7.0 Hz, 2H, 
CH2
2
), 2.25 (quintet, J=7.5 Hz, 2H, CH2
3'
















), 154.11 (Cf-2, 5, 8, 10), 146.85 (Cf-52, 60), 145.80 (Cf-32, 39, 41, 48), 145.62 (Cf-3, 4, 25, 26), 
 S5 
145.46 (Cf-51, 53, 56, 59), 145.18 (Cf-21, 30), 145.01 (Cf-14, 19, 23, 28), 144.84 (Cf-49, 50, 54, 55), 144.09 
(Cf-33, 38, 42, 47), 142.65 (Cf-31, 40), 142.19 (Cf-35, 36, 57, 58), 141.68 (Cf-13, 20, 22, 29), 141.63 (Cf-34, 






















); IR: ν=3426, 2926, 1655, 1544, 1427, 1186, 1135, 1078 cm-1; 







MS: m/z: calcd for C76H28N5O6: 1106.20341 [M+H]
+
, found 1106.20491. 
Fp-GABA3-Gly-OH (Fp-G''-G'-G-Gly-OH) 10 
Starting from tert-butyl ester (147 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 10 (138 mg, 99 %) 
was obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=7.79 (br.t, J=5.5 Hz, 1H, NH
Gly
), 7.72 (br.t, J=5.5 
Hz, 1H, NH
 GABA'
), 7.70 (br.t, J=5.5 Hz, 1H, NH
 GABA
), 4.57 (s, 4H, CH2
pyrr.
), 3.93 (d, J=5.5 Hz, 2H, CH2
Gly
), 
3.26 (q, J=6.0 Hz, 2H, CH2
4'
), 3.25 (t, J=6.0 Hz, 2H, CH2
4''
), 3.24 (q, J=6.5 Hz, 2H, CH2
4
), 2.56 (t, J=7.5 Hz, 
2H, CH2
2''




), 2.22t (t, J=7.0 Hz, 2H, CH2
2'














), 154.02 (Cf-2, 5, 8, 10), 147.01 (Cf-52, 60), 145.96 (Cf-32, 39, 41, 48), 145.77 (Cf-
3, 4, 25, 26), 145.54 (Cf-51, 53, 56, 59), 145.32 (Cf-21, 30), 145.17 (Cf-14, 19, 23, 28), 144.99 (Cf-49, 50, 54, 
55), 144.22 (Cf-33, 38, 42, 47), 142.80 (Cf-31, 40), 142.35 (Cf-35, 36, 57, 58), 141.80 (Cf-13, 20, 22, 29), 
141.77 (Cf-34, 37, 43, 46), 141.61 (Cf-16, 17, 44, 45), 139.87 (Cf-15, 18, 24, 27), 135.88 (Cf-6, 7, 11, 12), 























); IR: ν=3427, 2928, 1646, 1544, 1430, 
1187, 1136, 1077 cm
-1







); ESI-TOF-MS: m/z: calcd for C76H29N4O5: 1077.21325 [M+H]
+






Starting from tert-butyl ester (155 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 11 (146 mg, 99%) was 
obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=7.92 (br.t, J=5.5 Hz, 1H, NH
Gly2
), 7.86 (br.t, J=5.5 
Hz, 1H, NH
Gly1
), 7.74 (br.t, 1H, J=6.0 Hz, NH
GABA'
), 7.69 (br.t, J=6.0 Hz, 1H, NH
GABA
), 4.64 (s, 4H, 
CH2
pyrr.
), 3.95 (d, J=5.5 Hz, 2H, CH2
Gly1
), 3.90 (d, J=6.0 Hz, 2H, CH2
Gly2
), 3.31 (t, J=7.5 Hz, 2H, CH2
4''
), 3.25 
(q, J=7.0 Hz, 2H, CH2
4'
), 3.23 (q, J=6.0 Hz, 2H, CH2
4
), 2.56 (t, J=7.0 Hz, 2H, CH2
2''





), 2.22 (t, J=7.5 Hz, 2H, CH2
2'




C NMR (125 











), 153.75 (Cf-2, 5, 8, 10), 147.02 (Cf-52, 60), 145.97 (Cf-32, 39, 41, 48), 145.78 (Cf-3, 4, 25, 
26), 145.45 (Cf-51, 53, 56, 59), 145.30 (Cf-21, 30), 145.19 (Cf-14, 19, 23, 28), 145.00 (Cf-49, 50, 54, 55), 
144.21 (Cf-33, 38, 42, 47), 142.80 (Cf-31, 40), 142.36 (Cf-35, 36, 57, 58), 141.77 (Cf-13, 20, 22, 29), 141.75 
(Cf-34, 37, 43, 46), 141.61 (Cf-16, 17, 44, 45), 139.87 (Cf-15, 18, 24, 27), 135.89 (Cf-6, 7, 11, 12), 69.74 (Cf-

























); IR: ν=3291, 3089, 2934, 
1650, 1547, 1428, 1196, 1136, 1079 cm
-1
; UV/Vis (CHCl3): λmax (ε)=430 (3000), 319 (28000), 306 (29000), 

















Starting from tert-butyl ester (162 mg, 0.13 mmol) in TFA/DCM (1:1, 4 mL) the acid 12 (154 mg, 100%) 
was obtained. 
1
H NMR (500 MHz, CDCl3/CS2/CD3OH): δ=8.19 (br.t, J=6.0 Hz, 1H, NH
Gly2
), 8.12 (br.t, 
J=6.0 Hz, 1H, NH
Gly3
), 7.88 (br.t, J=5.5 Hz, 1H, NH
Gly1
), 7.81 (br.t, 1H, J=5.5 Hz, NH
GABA'
), 7.71 (br.t, 
J=5.5 Hz, 1H, NH
GABA
), 4.63 (s, 4H, CH2
pyrr.
), 3.93 (d, J=5.5 Hz, 2H, CH2
Gly1
), 3.92 (d, J=5.0 Hz, 2H, 
CH2
Gly2
), 3.86 (d, J=5.5 Hz, 2H, CH2
Gly3
), 3.30 (t, J=7.5 Hz, 2H, CH2
4''
), 3.25 (q, J=6.5 Hz, 2H, CH2
4'
), 3.22 
(q, J=6.5 Hz, 2H, CH2
4
), 2.57 (t, J=7.0 Hz, 2H, CH2
2''
), 2.29 (t, J=7.0 Hz, 2H, CH2
2
), 2.28 (qui., 2H, CH2
3''
), 
2.22 (t, J=7.5 Hz, 2H, CH2
2'
), 1.81 (qui., J=6.5 Hz, 2H, CH2
3'


















), 153.74 (Cf-2, 5, 8, 10), 146.97 (Cf-52, 60), 145.92 (Cf-32, 39, 41, 48), 
145.73 (Cf-3, 4, 25, 26), 145.41 (Cf-51, 53, 56, 59), 145.25 (Cf-21, 30), 145.14 (Cf-14, 19, 23, 28), 144.95 
(Cf-49, 50, 54, 55), 144.16 (Cf-33, 38, 42, 47), 142.76 (Cf-31, 40), 142.31 (Cf-35, 36, 57, 58), 141.72 (Cf-13, 
 S6 
20, 22, 29), 141.71 (Cf-34, 37, 43, 46), 141.56 (Cf-16, 17, 44, 45), 139.82 (Cf-15, 18, 24, 27), 135.85 (Cf-6, 7, 




























); IR: ν=3416, 2929, 1651, 1546, 1426, 1188, 1135, 1078 cm-1; UV/Vis (CHCl3): λmax (ε)=430 (3600), 






); ESI-TOF-MS: m/z: calcd for C80H35N6O7: 
1191.25617 [M+H]
+











C NMR chemical shifts of the peptide moiety of fullerene acids 
13C/1H FpG FpG2 FpG3 FpGGly FpGGly2 FpGGly3 FpG2Gly FpG2Gly2 FpG2Gly3 FpG3Gly FpG3Gly2 FpG3Gly3 
CO(1) 179.81 175.61 175.71 173.72 173.92 174.38 173.98 174.04 174.42 173.97 173.99 174.50 
CO(1')  173.62 173.77    173.74 173.86 173.79 173.82 173.78 173.80 









































CH2(2'')   33.76 
2.57t 














































CH2(3'')   23.83 
2.30qui 















































CH2(4'')   54.04 
3.31t 









































3)      42.62 
3.934d 
  42.54 
3.85d 
  42.74 
3.86d 
CO(Gly1)    171.31 171.19 171.39 171.69 171.47 171.35 171.70 171.48 171.42 
CO(Gly2)     169.71 169.82  170.04 169.92  170.12 170.07 
CO(Gly3)      170.10   170.26   170.43 
NH(G)  7.58br.t 7.52br.t    7.74br.t 7.68br.t 7.78br.t 7.70br.t 7.69br.t 7.71br.t 
NH(G')   7.72br.t       7.72br.t 7.74br.t 7.81br.t 
NH(Gly1)    7.76br.t 7.86br.t 7.91br.t 7.76br.t 7.85br.t 7.91br.t 7.79br.s 7.86br.t 7.88br.t 
NH(Gly2)     7.93br.t 8.06br.t  7.92br.t 8.16br.t  7.92br.t 8.19br.t 
NH(Gly3)      8.09br.t   8.13br.t   8.12br.t 



































































































































Figure S2 SEM images of compounds 2-12 prepared from PhMe/MeOH (5/1, v/v) mixture on a Si substrate 
upon evaporation of 10 μl of 1mM solution at room temperature; inset on 3: 10 μL of 0.1mM solution; 9 and 
10, right, 30 μL of 1mM solution. 
